Primmune Therapeutics
www.primmunerx.comPrimmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
Read more
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
Read more
Country
State
California
City (Headquarters)
San Diego
Industry
Employees
1-10
Founded
2017
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Chairman and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Business Officer and Co - Founder
Email ****** @****.comPhone (***) ****-****Chief Commercial Officer
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Primmune Therapeutics
Free credits every month!
Primmune Therapeutics FAQ
San Diego, United States
Pharmaceutical Manufacturing
